Ani Michaud

Company: Promega

Job title: Research Scientist

Seminars:

Exploring Novel Vulnerabilities for Type II RAF Inhibitors in Living Cells With NanoBRET 11:30 am

New NanoBRET assay technology to quantify type II RAF inhibitor occupancy at individual protomers within RAS/RAF complexes Compared to BRAF and CRAF, clinical-stage drugs escape ARAF inhibition in cells Additional application of NanoBRET technology to study conformation-selective DFG-OUT inhibitors across the broader kinomeRead more

day: Day One Track A AM